Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?

[cafead]

via

• Boehringer Ingelheim terminated a partnership with CureVac on an mRNA lung cancer vaccine program.
• The cancellation of this deal shouldn't impact other mRNA cancer vaccine programs for Moderna, BioNTech, and other biotech companies.

article source